Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Afternoon El. How do you judge the large trades today ? Looks some decent sized buys in that lot. Volume up again which is great at this level, investors not interested at 1.5p only a few weeks ago.
Hi Bob. I enjoy the technical predictions of those who know much more than I about such things and it does give some confidence going forward, the sentiment has clearly changed now and now significant seller putting downward pressure has nearly gone. I believe the price predictions to be low. The board quality and expertise is superb and AI is increasingly in the news both at a clinical and political level. The first announcement of clinical use of Texrad software will be a game changer and the pre curser to acceptance of many more in NHS in my opinion. CEO expects Texrad lung to be widely used in UK and Europe before year end. When this happens the gates will open to AI in many oncology clinical settings, again in my view. I expect �50million company within 12 months.
New house got room for the 3 amigos?!!
Morning mate. Serious healthcare quality individuals in this company now at board level. Another great appointment to work alongside Balaji and roll out products in clinical sector. New man a respiratory consultant and we are looking at Texrad for COPD etc. Ducks lining up and clearly lots being developed in background. Expect a great second half to 2018 and still a buyer at these levels. Good luck and hope house move went well and you settled.
Evening El, what do you make of those enormous trades?
Interesting day, good recovery for the bulls, decent sized trades and a 1 code as well. RNS tomorrow if you believe in such things.
Afternoon El, 500,000 trade marked as sell, what do you reckon?
Hi Bob. The corporate infrastructure is in place and BG concentrated efforts on sales, which is his strength. As usual the quiet periods on AIM can lead to retrace but reasonably assume the new board are working socks off to develop commercial deals. It's still hugely about Texrad lung integration into clinical settings and CEO has publicly stated this will be in place in UK and Europe in 2018. Hope all good with you.
Morning El! Great endorsement of AI and Feedback leads the way in medical imaging with multi peer reviewed papers on Texrad cancer imaging product. Prime time for Fdbk. Enjoy fantastic summer weather today.
Cheers El, TB he's like a nagging toothache, by the way how are you after dentist visit, all good now?
Hold your breath mate, not many left now!
Afternoon Bob, Botak, El and all. Agree Bob, TB nearly gone and good to see his stock being bought in decent quantities. Without the downward pressure and a little decent news will return to recent highs. NED bought at 3.5p.
Morning! Could be remaining TB shares being sold in background, having gone below 3% expect him to sell all now.
Sad day for you El. We lost Wes Hoolahan as you know and like Wes Ian is a true football man in the great old fashion where loyalty and passion counted for much. Wes is going to get a testimonial but presumably not Ian. I read bis biography and really enjoyed it, a great family man and comedian outside of football who never seemed to take himself too seriously. I hope you get someone who has the same passion for APR.
Hi El, who has left QPR?
Yesterday by TB. Says a huge amount for company situation that sale absorbed at little cost to SP. Someone must be picking them up. How many left now El?
Hi guys. Last few days seem to be almost like an arranged transfer from seller (TB) to very willing buyers. Would expect more TR1s shortly. Certainly trade sizes are more significant of late. Technically 2.65 represents a decent support level. IMO
Hi El, What do reckon to Friday after hours trade? Buy or TB offload? Best wishes
Trevor Brown down to 4% holding offloaded 9 million shares with minimal impact on share price. Oh how things have changed.....
We have seen, - 52 weeks low share price of around 1.24 - fundraising of �440k at around existing share price at the time (rarity on AIM) - lack of sell off of shares from placing (sticky holders) - increase in volumes and number of trades - current share increase of 150% - solid support developing at 2.75/2.85 giving consolidation at current share price - NED buying shares at 3.50 on open market - newsflow including commercial deals for Texrad with global giant GE Healthcare - contract signed for delivery of archiving system to Papworth Hospital, leading UK hospital What's not to like? Enjoy the long weekend everyone!